| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |